Congress Asset Management CO Jazz Pharmaceuticals PLC Transaction History

Congress Asset Management CO

$14.3 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$119.87 - $145.67 $440,761 - $535,628	-3,677 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$128.64 - $184.79 $7,847 - $11,272	-61 Reduced 1.63%	3,677 $479,000
Q2 2021 Aug 05, 2021	BUY	$160.2 - $186.42 $480 - $559	3 Added 0.08%	3,738 $664,000
Q1 2021 May 05, 2021	SELL	$150.19 - $173.5 $39,499 - $45,630	-263 Reduced 6.58%	3,735 $614,000
Q4 2020 Jan 26, 2021	SELL	$140.71 - $165.05 $5,065 - $5,941	-36 Reduced 0.89%	3,998 $660,000
Q3 2020 Nov 03, 2020	SELL	$105.46 - $144.13 $293,600 - $401,257	-2,784 Reduced 40.83%	4,034 $575,000
Q2 2020 Jul 23, 2020	SELL	$95.68 - $121.88 $52.1 Million - $66.4 Million	-544,761 Reduced 98.76%	6,818 $752,000
Q1 2020 Apr 21, 2020	BUY	$87.74 - $152.74 $531,002 - $924,382	6,052 Added 1.11%	551,579 $55 Million
Q4 2019 Feb 10, 2020	BUY	$117.65 - $153.73 $590,720 - $771,878	5,021 Added 0.93%	545,527 $81.4 Million
Q3 2019 Nov 01, 2019	BUY	$125.18 - $143.24 $1.04 Million - $1.19 Million	8,289 Added 1.56%	540,506 $69.3 Million
Q2 2019 Aug 07, 2019	SELL	$125.55 - $144.48 $257,628 - $296,472	-2,052 Reduced 0.38%	532,217 $75.9 Million
Q1 2019 May 08, 2019	BUY	$121.81 - $142.95 $7.91 Million - $9.28 Million	64,931 Added 13.83%	534,269 $76.4 Million
Q4 2018 Jan 25, 2019	SELL	$115.94 - $166.74 $3.91 Million - $5.62 Million	-33,685 Reduced 6.7%	469,338 $58.2 Million
Q3 2018 Oct 26, 2018	SELL	$161.01 - $180.57 $565,467 - $634,161	-3,512 Reduced 0.69%	503,023 $84.6 Million
Q2 2018 Jul 25, 2018	BUY	$146.33 - $183.18 $74.1 Million - $92.8 Million	506,535 New	506,535 $87.3 Million

Others Institutions Holding JAZZ

# of Institutions

513

Shares Held

57.5M

Call Options Held

188K

Put Options Held

133K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.61B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

News

Stay updated on Congress Asset Management CO with notifications on news.

Account